The underlying cell types mediating predisposition to obesity remain largely obscure. Here we first integrated recently published single-cell RNA-sequencing (scRNA-seq) data from >380 peripheral and nervous system cell types spanning 19 mouse organs with body mass index (BMI) genome-wide association study (GWAS) data from >450,000 individuals. Leveraging a novel strategy for integrating scRNA-seq data with GWAS data, we identified 22, exclusively neuronal, cell types from the subthalamus, midbrain, hippocampus, thalamus, cortex, pons, medulla, pallidum that were significantly enriched for BMI heritability (P<1.6x10 -4 ). Using genes harboring coding mutations leading to syndromic forms of obesity, we replicate four midbrain cell types from the anterior pretectal nucleus, superior nucleus, periaqueductal gray and pallidum (P<1.7x10 -4 ). Testing an additional set of 347 hypothalamic cell types, ventromedial hypothalamic steroidogenic-factor 1 (SF1) and cholecystokinin b receptor (CCKBR)-expressing neurons (P=4.9x10 -5 ) previously implicated in energy homeostasis and glucose control and three cell types from the preoptic area of the hypothalamus and the lateral hypothalamus enriched for BMI GWAS associations (P<4.9x10 -5 ).
INTRODUCTION
Identification of genes and cell types underlying susceptibility to human obesity remains a critically important step towards a better understanding of mechanisms causing the disease 1 . Studies of monogenic obesity syndromes and rodent models of obesity have identified melanocortin signaling circuits in the mediobasal and paraventricular hypothalamus as key components in energy homeostasis and obesity [2] [3] [4] .
Yet growing evidence suggests that susceptibility to obesity is distributed across numerous brain areas that receive signals emanating from internal sources (e.g., viscerosensory input from the gastrointestinal tract) or external stimuli (e.g., the sight or smell of food) that act in concert to regulate feeding behavior and energy stores [5] [6] [7] . However, despite an increasing number of genes, cell types and neuronal circuits being implicated in murine energy homeostasis, the identity of brain cell types that drive susceptibility to human obesity remains largely unknown and a systematic assessment of cell types' relevance in obesity is currently lacking.
In recent years, genome-wide association studies (GWAS) have identified about a thousand common (minor allele frequency, MAF≥0.1) single nucleotide polymorphisms (SNPs) that associate with body mass index (BMI, defined as weight in kilogram divided by height in meters squared), a heritable and commonly used proxy phenotype for obesity 8, 9 . In general, the far majority of trait-associated SNPs are located in regulatory regions and hence, unlike coding variants, tagging genetic intervals (or loci) rather than implicating specific genes. Importantly, these loci represent an unbiased set of biological sign posts to genes and biological mechanisms underlying susceptibility to obesity 10 .
Genetic variants with rare frequencies (MAF<0.1) that are typically too low to be captured in GWAS are thought to contribute ~50% to the heritability of BMI 11 . Many such variants are coding mutations 11 and hence well-suited to identify causal genes underlying obesity. Lately, rare variant association studies have identified 14 coding variants across 13 genes in an exome chip analysis across >750,000 individuals 12 .
Interestingly, these genes, with the exception of MC4R, KSR2 and GIPR, have not previously been implicated in obesity, suggesting that key biologic mechanisms underlying obesity have yet to be identified.
Given that a majority of obesity-associated gene variants likely regulate gene expression rather than impact protein function, gene expression data provide an effective scaffold to inform GWAS data for obesity and other traits [13] [14] [15] [16] . In 2016, we used microarray-based gene expression data to show that genes in BMI GWAS loci are predominantly expressed in the brain 8 and we recently leveraged mouse singlecell RNA-sequencing (scRNA-seq) to implicate mediobasal hypothalamic cell types in obesity 17 . The growing number of BMI GWAS loci and genes implicated through rare-variant association studies of common and syndromic forms of obesity, in conjunction with the growing number of large-scale scRNAseq atlases, provide a unique opportunity to systematically uncover genes and cell types underlying biological circuits regulating susceptibility to human obesity.
Here we developed two computational toolkits for human genetics-driven identification of cell types underlying disease and leveraged them to systematically identify cell types enriching for obesity susceptibility by combining publicly available BMI GWAS summary statistics from >450,000 individuals with scRNA-seq data spanning 380 cell types representing adult mouse organs especially the nervous system and 347 cell types from the adult mouse hypothalamus.
RESULTS

Devising a robust cell type expression specificity metric and prioritization framework
Similar to previous approaches [17] [18] [19] [20] , we hypothesized that cell types exhibiting detectable expression of genes colocalizing with BMI GWAS loci are more likely to underlie obesity than cell types in which the expression of genes is low. Based on this reasoning, we developed CELLECT (Cell type Expression- 4 specific integration for Complex Traits) and CELLEX (Cell type EXpression-specificity), two toolkits for genetic identification of likely etiologic cell types. Given GWAS summary statistics and scRNA-seq data, CELLECT can quantify the enrichment of heritability in or near genes specifically expressed in a given cell type using established genetic prioritization models, such as S-LDSC 13 , RolyPoly 14 , DEPICT 15 or MAGMA covariate analysis 18 (Methods; Fig. 1a ). Importantly, whereas previous frameworks for genetic prioritization of cell types have either relied on non-polygenic models 17 , used binary or discrete representations of cell type expression 13, 18 or used average expression profiles 20 , CELLECT uses a robust continuous representation of cell type expression. In Supplementary Notes 1,2 we provide a detailed discussion of our model, its assumptions and relationship to the 'omnigenic' model hypothesis 21, 22 . Conjointly, CELLEX was built on the observation that different measures of gene expression specificity (ES) provide complementary information and therefore combines four ES metrics (see Methods) into a single measure (ESμ) representing the score that a gene is specifically expressed in the given cell type (Methods; Fig. 1b) . Our ES approach was tested and validated using the Tabula Muris dataset 23 , a Smart-Seq2 scRNA-seq dataset derived from 20 organs from adult male and female mice, and the Mouse Nervous System dataset 24 , derived from 19 central and peripheral nervous system regions from late-postnatal male and female mice. Based on a total of 53,760 cells, we computed gene expression specificity for the four metrics and combined them into ESμ across four cell types with known marker genes and found that ESμ correctly identified them as being among the most specifically expressed genes ( Fig. 1d,e; Supplementary Results) . We identified a median of 2,934 specifically expressed genes per cell type and hierarchical clustering of cell types based on the ESμ estimates largely reproduced the cell type dendrograms from the respective original publications 23, 24 , confirming that our ES approach enables cell types profiles to be compared across studies and technologies ( Supplementary Fig. 1,2) . In Supplementary Note 3 we provide a detailed description of the CELLEX workflow, its assumptions and we use re-sampling to demonstrate the robustness of ESμ compared to individual ES metrics. Both CELLECT and CELLEX have been implemented and released as open-source packages for Python 5 programming languages (URLs). Here, we used CELLECT with S-LDSC as the genetic prioritization model to quantify the effects of cell type ES on BMI heritability. For each cell type, we reported the Pvalue for the one-tailed test for positive contribution of the cell type ES to trait heritability (conditional on a 'baseline model' that accounted for the non-random distribution of heritability across the genome, see Methods).
BMI variants enrich for central nervous system rather than peripheral cell types
Using BMI GWAS summary statistics from a GWAS analysis of the UK Biobank 25 comprising >457,000 individuals 26 and the Tabula Muris cell types, we first assessed whether we could replicate the exclusive enrichment of BMI GWAS variants in brain tissues as reported by Locke et al. 8 ( Supplementary Tables 1-3) . Applying CELLECT to the 115 -mostly peripheral -cell types, we identified two significantly enriched cell types, namely neurons and oligodendrocyte precursor cells (Bonferroni correction-based false-discovery rate, FDR<0.05; Fig. 2a , Supplementary Table 4 ). When rerunning CELLECT conditioning the neuron cell type, the oligodendrocyte precursor cell type was not significant any longer, emphasizing that we primarily observed a neuron signal for GWAS BMI variants.
In order to verify that our approach, in general, could identify relevant cell types for complex traits, we computed enrichments for nine GWAS including cognitive, psychiatric, neurological, immunological, lipid and anthropometric traits and disorders, and found that CELLECT prioritized etiologically relevant cell types across all six categories ( Fig. 2b, Supplementary Table 4 ). Thus, cortical neurons were prioritized for cognitive traits and psychiatric disorders (educational attainment, intelligence, schizophrenia), neuronal cell types for insomnia, immune cells for multiple sclerosis and rheumatoid arthritis, growth-related cell types for waist-to-hip ratio (adjusted for BMI) and height, and hepatocytes for low-density lipoprotein levels (see Supplementary Table 4 for results across additional 29 traits).
These data establish the ability of this approach to validate previous evidence 8 that BMI variants tend to 6 colocalize with genes specifically expressed in neurons, while also demonstrating that CELLECT is able to prioritize relevant cell types across a number of complex traits.
A distributed set of neuronal cell types enrich for obesity susceptibility
We next assessed whether we could identify specific CNS cell types enriching for BMI-associated variants. Applying CELLEX and CELLECT on 265 cell types from the mouse nervous system, we identified 22 enriched cell types annotated to eight brain regions ( Fig. 3a; Supplementary Table 5,6) . To assess the specificity of the BMI signal in these 22 cell types, we computed enrichments for the panel of nine other well-powered traits. As expected, none of the five traits primarily caused by peripheral etiologies enriched for any nervous system cell type and several of 22 BMI GWAS-enriched cell types also enriched for cognitive traits and psychiatric disorders ( Fig. 3b; Supplementary Table 5 ). Sixteen of the 22 cell types were also enriched "intelligence" and "worry", two traits genetically anticorrelated with obesity (overlapping sets of associated loci with opposite effect sizes) 27, 28 ( Supplementary Table 7 ).
Similar to previous work, we did not find any enrichment of genetic variants associated with BMI in nonneuronal cell types 17, 20 nor did we detect enrichment for a particular type of neurotransmitter type ( Supplementary Fig. 5 ). Weighted correlation network analysis (WGCNA, 29 ) on expression data from each of the 22 BMI-enriched cell types identified no significant modules ( Supplementary Fig. 4 ; Supplementary Tables 8,9 ; top associated module, P=1.88x10 -4 ; FDR£0.1). These findings emphasize that the BMI-associated variants most likely are distributed across hundreds of genes rather than the relatively limited number of genes captured in cell type-specific WGCNA modules (see Supplementary Note 4 for a discussion on limitations of identifying gene co-expression networks from cell type scRNAseq data).
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To assess the dependence of the results on a given enrichment methodology and BMI GWAS, we recomputed enrichments using the Yengo et al. 9 and Locke et al. 8 BMI GWAS summary statistics and the MAGMA tool 30 (Supplementary Tables 5,10 ). We observed that the results were robust to different Supplementary Fig. 5 ). Finally, during finalizing this work another study focused on Parkinson's disease, reported BMI GWAS enrichments for the same mouse nervous system cell types (overlap; 6/10) 19 . Together, these results demonstrate that BMI-associated variants are likely to exert their effect across multiple, exclusively neuronal cell types, several of which enrich for cognitive traits and psychiatric disorders genetically correlated with obesity.
The enriched neuronal cell types share transcriptional similarities
The 22 cell types mapped to eight brain regions, namely the subthalamus, midbrain, hippocampus, thalamus, cortex, pons, medulla and pallidum ( Fig. 4a) . We next assessed whether shared transcriptional signatures could explain the enrichments across the 22 cell types. Towards that aim, we first clustered all cell types based on their genes' ESμ values and, expectedly, found that midbrain cell types overall grouped by their neuroanatomical proximities and neurotransmitter types into midbrain, hindbrain, hippocampus/cortex clusters ( Fig. 4b) . A notable exception was the DEINH3 cell type (isolated from the hypothalamus region and subsequently remapped to the subthalamic nucleus by Zeisel et al.) which grouped with the midbrain cell types. To further assess the transcriptional similarity between the enriched cell types, we computed enrichments conditioned on each prioritized cell type individually (Methods).
Contrary to our expectations, we found that none of the other cell types remained significant when conditioning on the top-ranked subthalamic cell type DEINH3 ( Supplementary Fig. 6,7 ; Supplementary Table 11 ). Together these results indicate the brain cell types enriching for BMI GWAS signal, despite their neuroanatomical differences, share transcriptional signatures related to obesity, which current methods are not able to disentangle.
Ventromedial hypothalamic Sf1-and Cckbr-expressing cells enrich for BMI GWAS
The total number of cell types in the hypothalamus has been significantly underestimated 31 , therefore to assess whether the lack of enrichment for hypothalamic cell types was due to sparse sampling of hypothalamic cells in the Mouse Nervous System dataset, we computed enrichments for an additional set of 347 cell types sampled from the mediobasal hypothalamus 17 , the ventromedial hypothalamus 31 , the lateral hypothalamus 32 , the preoptic nucleus of the hypothalamus 33 and the entire hypothalamus 34, 35 ( Supplementary Table 12 ). We identified four non-overlapping significantly enriched cell types, namely a ventromedial hypothalamic glutamatergic cell type (ARCME−NEURO29; P=4.9x10 -5 ) expressing Sf1 (ESμ=0.98 and ESμ=0.99), Cckbr (cholecystokinin B receptor; ESμ=0.98, ESμ=0.95); a glutamatergic cell type from the lateral hypothalamus (LHA-NEURO20; P=4.9x10 -5 ); two cell types from the preoptic area of the hypothalamus (POA-NEURO21 and POA-NEURO66; P<1.0x10 -4 ; Fig. 5 ; Supplementary Table   13 ,14). Interestingly, ventromedial hypothalamic neurons have previously been implicated in control of both body fat mass and blood glucose levels; disrupted leptin signaling in Sf1-expressing ventromedial hypothalamic neurons renders mice more susceptible to diet-induced weight gain 36 and activation of ventromedial hypothalamic Sf1 neurons causes hyperglycemia 37 . The two cell types also expressed Bdnf (ESμ=0.91, ESμ=0.99); mutations in BDNF and its receptor is a known cause of monogenic obesity in humans and, in mice, Bdnf signaling is required for normal energy homeostasis and glucoregulatory control 38 . (Bdnf and Ntrk2 were also specifically expressed in TEINH12 cell type, a cholecystokinin (Cck)-expressing interneuron, enriched in the Mouse Nervous System analysis, see Supplementary Results.) Notably, there was no significant enrichment for Agrp and Pomc neurons (coding mutations in POMC can cause syndromic obesity in humans), however, two Pomc cell populations were nominally enriched (HYPR-NEURO24 35 , P=0.002; ARCME-NEURO21 17 , P=0.01). In sum, although we 9 identified enrichment in four -exclusively neuronal cell types -the overall BMI GWAS enrichment in hypothalamic cell types was surprisingly limited.
Genes with known links to human obesity genes implicate the dorsal midbrain
As genes that have been associated with obesity through sequencing and large-scale exome chip association analysis have been identified independently of the results from GWAS, we reasoned that we could use them to validate the cell types enriched for BMI GWAS signal. Combining a set of 39 obesity genes associated with syndromic forms of obesity (obtained from Turcot et al. 12 ) and 13 genes with rare but high-effect size mutations implicated by the Turcot et al. study, we computed the enrichment of a total set of 50 unique obesity genes ( Supplementary Table 15 ) within all 265 Mouse Nervous System cell types. We identified 15 significantly enriched cell types (one-sided Mann-Whitney U test, FDR<0.05) of which four replicated cell types from the BMI GWAS analysis (DEGLU5, MEGLU1, MEGLU2 and TEINH1 from the anterior pretectal nucleus, the superior colliculus, the periaqueductal grey and the pallidum; P<1.7x10 -4 ; (Supplementary Fig. 8 , Supplementary Table 16 ). Among the remaining 11 cell types, 10 originated from areas implicated by the CELLECT analysis, namely the midbrain (MBDOP1, periaqueductal grey; MEINH4, the anterior pretectal nucleus; MEGLU6, superior colliculus; MEGLU14, the dorsal raphe nucleus), the hypothalamus (HYPEP1, lateral hypothalamus; DEINH5, the medial preoptic nucleus and bed nuclei of the stria terminalis anterior division; and the dorsomedial nucleus of the hypothalamus), the medulla (HBSER4, nucleus raphe medulla; HBNOR, A1-2 noradrenergic cell groups) and the thalamus (DEINH4, paraventricular nucleus of the thalamus; Fig.   6a ). We observed a significant correlation between the rare variant obesity geneset and CELLECT cell type enrichment results (Pearson's R=0.58, P=1.7x10 -25 ; Supplementary Fig. 9a ), which further underscored the validity of our findings and, as previously reported 8 , that genes implicated in syndromic obesity tend to colocalize with BMI-associated GWAS loci ( Supplementary Fig. 9b ).
Interestingly, the leptin receptor, which regulates key energy homeostatic processes in the hypothalamus and when defective may cause syndromic obesity 39 was only specifically expressed in two out of the 22 BMI GWAS-enriched cell types, namely glutamatergic cells from the periaqueductal grey and anterior nucleus of the solitary tract ( Fig. 6a) . By contrast, 17 of the enriched cell types expressed the serotonin receptor 5-Htr2c (5-hydroxytryptamine receptor 2C), a known regulator of energy and glucose homeostasis 40 and the target for current obesity pharmacotherapy 41 (Fig. 6b) . 5-Htr2c was most specifically expressed in the anterior pretectal nucleus (DEGLU5, ESμ=0.96), the cell type among our results which most specifically expressed Pomc (ESμ=0.41). Mice lacking the Htr2c in Pomc neurons are resistant to 5-Htr2c agonist Lorcaserin-induced weight loss 40 (For ESμ plot of other selected genes, please refer to Supplementary Fig. 10 ).
Together these results indicate that susceptibility to obesity conferred by common variants, while enriching for some hypothalamic cell types such as VMH Sf1-expressing neurons, is distributed across a mosaic of neuronal cell types of which numerous are involved in regulating integration of sensory stimuli, learning and memory.
DISCUSSION
Here, we developed two scRNA-seq computational toolkits called CELLEX and CELLECT and applied them to scRNA-seq data from a total of 727 mouse cell types, from mostly adult mice, to derive an unbiased map of cell types enriching for human genetic variants associated with obesity. In total, we identified 26 neuronal cell types, which, in line with previous considerations 5 , demonstrate that susceptibility to human obesity is likely to be distributed across multiple, mainly neuronal, cell types across the brain, rather than being mostly restricted to a limited number of canonical energy homeostasisand reward-related brain areas in the hypothalamus, midbrain and hindbrain. Among the enriched hypothalamic cell types, we identified VMH Sf1-and Cckbr-expressing neurons, which previously have been implicated in glucose and energy homeostasis.
Processing of sensory stimuli and feeding behavior
Several of the BMI GWAS enriched cell types localized to nuclei integrating sensory input and directed behavior. The inferior colliculus (implicated by MEGLU7, MEGLU10 and MEGLU11) and medial geniculate nucleus (MEINH3) process auditory input, the superior colliculus for translation of visual input into directed behavior (MEGLU1 and MEGLU6), the anterior pretectal nucleus processes somatosensory input (DEGLU5 and MEINH4), and the piriform cortex (TEGLU17) and anterior olfactory nucleus (TEGLU19) processing odor perception. The superior colliculus and anterior pretectal nucleus have both implicated in predatory behavior 42, 43 and project to the zona incerta, a less welldescribed brain area situated between the thalamus and hypothalamus that receives direct input from mediobasal hypothalamic Pomc neurons 44 . In rats, lesioning of the zona incerta impairs feeding responses 45 while, conversely, in mouse models, optogenetic stimulation of GABAergic neurons in the zona incerta leads to rapid, binge-like eating and body weight gain 46 . Activation of projections from the hypothalamic preoptic nucleus (DEINH5; POA-NEURO21, POA-NEURO66) to the ventral periaqueductal gray (MEGLU2 and MBDOP1) induce object craving 47 , whereas pharmacological inactivation of the periaqueductal gray decreases food consumption 48 . Together, these findings suggest that susceptibility to obesity is enriched in cell types processing sensory stimuli and directing actions related to feeding behavior and opportunity.
Evidence supporting a key role of the learning and memory in obesity
Feeding is not an unconditioned response to an energy deficiency but rather reflecting behavior conditioned by learning and experience 49 . We previously showed that genes in BMI GWAS loci enrich for genes specifically expressed in hippocampal post-mortem gene expression data 8 . In this work, we identified specific brain cell types supporting a role of memory in obesity. First, the parafascicular nucleus (DEGLU4), when lesioned in mice, reduces object recognition memory 50 . Second, the retrosplenial cortex (TEGLU4) is responsible for decisions made on past experiences 51 . Third, among the two enriched glutamatergic hippocampal cell types (TEGLU21 and TEGLU23), the latter expresses lipoprotein lipase as one of its top marker genes, an enzyme that causes weight gain when pharmacological or genetically attenuated in mice 52 . Similarly, fasting inhibits activation of hippocampal CA3 cells (based on c-fos levels) in mice 53 and activation of glutamatergic hippocampal pyramidal neurons increases future food intake in rats most likely by perturbing memory consolidation related to the previous meal 54 . In sum, our results provide further evidence that processes related to learning and memory play a key role in human obesity, and provide insights into specific cell types underlying hippocampal-centric susceptibility to obesity.
Limitations of our approach
Our results should be interpreted in the light of the underlying data used to prioritize the cell types. First, the scRNA-seq data analyzed in the paper were derived from late postnatal (Mouse Nervous System dataset) and adult mice and hence did not cover developmental states and cell types of potential importance to obesity 6 . Second, the datasets used in this work should not be regarded as complete atlases because they are likely to miss relevant cell types (from for example the paraventricular hypothalamus, nodose ganglia and adipocytes) and cell states. Third, one should keep in mind the overall assumption behind our approach, namely that in order for a disease to manifest in a given tissue or cell type the set of disease-causing genes must be active and expressed in the given tissue or cell type. In other words, our model presupposes that high/increased expression (and not decreased/lack-of expression) of a gene results in disease. Thus, our approach is not designed to detect cell types in which reduced expression of a specific gene predisposes to obesity. Fourth, our approach assumes that cell type specific patterns of gene expression are highly homologous between humans and mice. Finally, additional work is needed to 13 further characterize the prioritized cell types during embryonal and postnatal development and relevant murine physiological regimes. While the high polygenicity of obesity and the inaccessibility of the human brain complicate approaches to further establish the enriched cell types' relevance in human obesity, we believe that combinations of functional imaging techniques, postmortem single-nucleus analyses, enhancers to gene maps and fine-mapping of BMI GWAS loci will be crucial to better understand their role in human obesity.
Relevance to human obesity
Despite these limitations, several lines of evidence suggest that the cell types identified herein to be enriched for BMI GWAS signal are relevant to human obesity. First, weight gain is the most pronounced side effect of subthalamic nucleus deep brain stimulation used to treat Parkinson patients 55 , an adverse side effect that may involve the DEINH3 cell type thought to reside in the subthalamic nucleus. Second, lorcaserin (Belviq), one of the few FDA-approved anti-obesity drugs, acts on the 5-HTR2C receptor to enhance serotonin signaling. Third, at the genetic level BMI is significantly correlated with attention deficit/hyperactivity disorder (ADHD) 56 , and growing evidence points to links between ADHD and eating disorders. For example, lisdexamfetamine (Vyvanse), a medication used to treat ADHD, is also used to treat binge eating 57 , while the ADHD medication methylphenidate (Ritalin) is known to reduce appetite 58 . These pharmacological observations suggest that the shared heritability of BMI and ADHD may involve pleiotropic gene variants acting through dorsal midbrain pathways. Fourth, genetic predisposition to obesity is protective to feelings of worry 59 , supporting our findings that these two traits are potentially acting through overlapping cell types in the dorsal midbrain. Finally, BMI variants associated with BMI in a GWAS conducted in Japanese individuals enriched most highly for enhancers active in the hippocampus 60 and maternal obesity is associated with reduced total hippocampal volume in reduced CA3 volume in children 61 . Together these observations support a model in which integration of 14 sensory signals, the dopamine system and memory are likely to play key roles in humans' susceptibility to obesity.
In conclusion, our results implicate specific brain nuclei regulating integration of sensory stimuli, learning and memory in human obesity and provide testable hypotheses for mechanistic follow-up studies. Our methodological framework provides a salient example of how human genetics data can be integrated with murine scRNA-data to identify and map components of brain circuits underlying obesity.
We provide easy to use computational toolkits, CELLECT and CELLEX, which we envision will greatly facilitate future functional interpretation of common and rare variant genetic association data.
METHODS
GWAS
For our primary analysis we obtained BMI GWAS summary statistics performed in UK Biobank participants (Nmax=457,824) 26 . To examine the robustness of our results to changes in GWAS cohort size, we performed secondary analyses on BMI GWAS summary statistics from two meta-analysis described (Nmax=322,154, European subset). We note that these two studies include individuals genotyped on custom array chips (Illumina Metabochip) which violate certain assumptions of S-LDSC, but show that this has a negligible effect on results. Supplementary Table 1 provides the full list of GWAS summary stats analyzed in this study. We used the script "munge_sumstats.py" (LDSC v1.0.0, URLs) to prepare all GWAS summary statistics. All prepared statistics were restricted to HapMap3 single nucleotide polymorphisms (SNPs), excluding SNPs in the major histocompatibility complex region (chr6:25Mb-34Mb; the term 'SNPs' and 'variants' will be interchangeably used throughout the Supplementary Notes). -LHA: Lateral Hypothalamic Area (from 32 , 10x Genomics protocol). We used the "dbCluster" annotations (n=43, of which 30 were defined as neuronal).
15
Single-cell RNA-seq datasets
-VMH: Ventromedial Hypothalamus (from 31 , SMART-seq and 10x Genomics protocols). We used the "smart_seq_cluster_label" annotations for the SMART-seq dataset (n=48, of which 40 were defined as neuronal) and the "tv_cluster_label" annotation for the 10x Genomics dataset (n=29, all defined as neuronal).
-HYPC: Pan hypothalamus (from 34 , DropSeq protocol). We used the "SVM_clusterID" annotations (n=45, of which 34 were defined as neuronal).
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-HYPR: Pan hypothalamus [from 35 , Fluidigm C1 protocol) dataset, we used the "level1 class" annotation for non-neuronal populations (n=6) and the "level2 class (neurons only)" annotation for neurons (n=54).
Code to download and reproduce preprocessing of all datasets are available via GitHub (URLs). Tables 2,3,12 lists cell type annotations, the number of cells per cell type and relevant meta-data for each dataset analyzed (for the Hypothalamus dataset we list the cell-type labels used in this study as well as and the cell-type labels used in the original studies).
Supplementary
Single-cell RNA-seq data pre-processing
For each dataset, we began with a matrix of gene expression values. We normalized expression values to a common transcript count (with n=10,000 transcripts as a scaling factor) and applied log-transformation ( ( + 1)). Next we excluded 'sporadically' expressed genes following the approach described in Skene et al. 18 using a one-way ANOVA with cell type annotations as the grouping factor and excluding all genes with P>10 -5 . We mapped mouse genes to orthologous human genes using Ensembl (v. 91), keeping only 1-1 mapping orthologs. See Supplementary Notes for a detailed description and discussion of the snRNA-seq data pre-processing.
CELLEX expression specificity
See Supplementary Notes for a detailed discussion on ES calculations, assumptions and limitations.
CELLEX version 1.0.0 was used to produce all results reported in this manuscript. A ready-to-use Python implementation of CELLEX can be retrieved from https://github.com/perslab/CELLEX. We calculated expression specificity separately for Tabula Muris, Mouse Nervous System and each of the hypothalamus datasets. Cell type expression specificity weights (ESw) were calculated using four expression specificity metrics (ES metrics) referred to us as Gene Enrichment Score (GES) 24 , Expression Proportion (EP) 18 , Normalized Specificity Index (NSI) 62 and Differential Expression T-statistic (DET). The mathematical formulas for the ES metrics can be found in Supplementary Notes. For each ES metric we separately computed gene-specific ESws before averaging them into a single ES estimate (ESμ) using the following steps:
1. For each cell type we determined the set of specifically expressed genes, * , by testing the null hypothesis that a gene is no more specific to a given cell type than to cells selected at random. We computed empirical P-values of ES weights by comparing observed weights to 'null' weights obtained by permuting the dataset's cell type annotations.
2. For each cell type we calculated ESw* representing the genes' score of being specifically expressed in a given cell type. We assumed that each cell type has a set of specifically expressed genes exhibiting a linearly increasing score reflecting its expression specificity. We modeled this linearity assumption by rank normalizing ESw for genes, g, in * : - * ( ) = rank 5 ( -( ))/| * | ∈ * - * ( ) = 0 ∉ * Note that ESw* are scaled such that - * ∈ [0,1].
3. For each cell type, we calculated ESμ, representing a gene's score of being specifically expressed in a given cell type, by taking the mean ESw* across all ES metrics (we here assume equal weighing of ES metrics).
We use 'ES genes' to denote the set of genes with ESμ>0 for a given cell type. Hence, all genes being part of at least one * for a specific cell-type will be included in the set of ES genes for this cell-type. Supplementary Fig. 1 and Supplementary Tables 2,3,12 show the number of ES genes for each cell type and dataset analyzed. We note that ES genes captures genes that were not only strictly specifically expressed (only expressed in the cell type) but also those that were loosely specifically expressed (i.e., 18 have higher expression in the cell type). All cell type prioritization results were based on the ESμ estimates.
CELLECT genetic prioritization of trait-relevant cell types
See Supplementary Notes for a detailed discussion on assumptions and limitations. CELLECT version 1.0.0 was used to produce all results reported in this manuscript. A ready-to-use Python implementation of CELLECT can be retrieved from https://github.com/perslab/CELLECT. Throughout this paper we report CELLECT cell type prioritization results using S-LDSC, as this model has been shown to produce robust results with properly controlled type I error 63 . Cell type prioritization results using MAGMA 30 can be found in Supplementary Fig. 5 and Supplementary Table 10 .
S-LDSC
We showed that most enhancers are located within 100 kb of their target promoters 64 . When a variant overlapped with multiple genes within the 100-kb window, we assigned the maximum ESμ value. The relatively large window size was chosen to capture effects of nearby regulatory variants, as the majority of trait-associated variants have been shown to be located in non-coding regions 65 . Our results were robust to changes in window size (data not shown), consistent with previous work 18, 63, 66 . Following the recommendation in 63 we constructed an "all genes" annotation for each expression dataset, by assigning the value 1 to variants within 100-kb windows of all genes in the dataset. We used hg19 (Ensembl v. 91) as reference genome for genetic variant and gene chromosomal positions. When constructing annotations, we used same 1000 Genomes Project SNPs 67 as in the default baseline model used in S-LDSC. Next we computed LD Scores for HapMap3 SNPs 68 for each annotation using the recommended settings.
For the primary cell type prioritization analysis, we jointly fit the following annotations: (i) the cell type annotation; (ii) all genes annotation (iii) the baseline model (v1.1). For cell type conditional analysis ( Supplementary Fig. 6 ) we added (iv) the cell type annotation conditioned on when fitting the model.
We ran S-LDSC with default settings and the workflow recommended by the authors. We reported Pvalues for the one-tailed test of positive association between for trait heritability and cell type annotation
ESμ. We note that the correlation structure among ESμ for cell type annotations can lead to a distribution of P-values that is highly non-uniform 63 . Highly significant P-values occur due to correlated cell types with true signal, whereas cell types negatively correlated with the true signal have P-values near 1. For all results, we used Bonferroni correction within a trait and dataset to control the FWER. We report the regression effect size estimate for each cell type (Supplementary Tables 6,7,12 ; "Coefficient" column), which represents the change in per-SNP heritability due to the given cell type annotation, beyond what is explained by the set of all genes and baseline model. We also report standard errors of effect sizes ("Coefficient std error" column), computed using a block jackknife 13 . Finally, we report the "annotation size" for each cell type, that measures the proportion of SNPs covered by the cell type annotation (0 means no SNPs were covered by the annotation; 1 means all SNPs were covered). Annotation size was computed as the mean of the cell type annotation.
S-LDSC heritability analysis
All S-LDSC heritability analysis and reported effect size estimates were obtained on the observed heritability scale, with the exception of heritability estimates for case-control traits shown in the barplots of Fig. 2a and Fig. 3b . Here we report heritability estimates on the liability scale using population 20 prevalences listed in Supplementary Table 1 . (The liability scale 
MAGMA cell type prioritization
To assess the robustness of the SNP-level S-LDSC cell type prioritization, we used an alternative genelevel approach inspired by 18 and tested the association of gene-level BMI association statistics with cell type ESμ using MAGMA (v1.07a) 30 . MAGMA was run with default settings to obtain gene-level association statistics calculated by combining SNP association P-values within genes and their flanking 100-kb windows into gene-level Z-statistics, while accounting for LD (computed using the 1000 Genomes Project phase 3 European panel; 67 ). Gene-level Z-statistic were corrected for the default MAGMA covariates: gene size, gene density (a measure of within-gene LD) and inverse mean minor allele count, as well the log value of these variables. Next, we used the R statistical language to fit a linear regression model using MAGMA gene-level Z-statistics as the dependent variable and cell type ESμ as the independent variable. We report cell type prioritization P-values (from the linear regression model) as the positive contribution of cell type ESμ regression coefficient to BMI gene-level Z-statistics (one-sided test).
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Cell type geneset enrichment
To assess cell type enrichment of genesets associated with obesity, we tested if members of the obesity geneset exhibited higher expression specificity (ESμ) in the given cell type than non-members of the geneset (all other genes in the dataset). Specifically, we used Mann-Whitney U test to obtain one-sided geneset enrichment P-values. We controlled the FWER using the Bonferroni method calculated over all cell types and the rare variant obesity geneset tested. As a precaution against unknown confounders, we also computed empirical p-values by permuting the expression specificity gene labels 10,000 times to obtain 'null genesets' of identical size, and obtained near-identical results (data not shown). We obtained genes with rare coding variants associated with obesity (n=13 genes) and genes implicated in syndromic obesity (n=39) from Turcot et al. (2018) Table 1 and Supplementary Table 21 , respectively. We combined these genes into a single geneset ('rare variant obesity geneset') consisting of unique 50 unique genes.
Cell type gene co-expression networks
We identified cell type gene co-expression networks using Weighted Gene Correlation Network Analysis (WGCNA) framework proposed by . To identify gene co-expression networks (henceforth referred to as gene modules) operating within a cell type, the input to WGCNA is expression data for individual cell types. Briefly our framework consisted of the following steps:
1. We normalized the raw expression values to a common transcript count (with n=10,000 transcripts as a scaling factor), log-transformed the normalized counts (log(x+1)), and centered and scaled each gene's expression to Z-scores. Cell clusters with fewer than 50 cells were omitted, and genes expressed in fewer than 20 cells were removed. We then used PCA to select the top 5000 highly loading genes on the first 120 principal components. We mapped mouse genes to orthologous human genes using Ensembl (v. 91), keeping only 1-1 mapping orthologs. 22 2. We then used hierarchical clustering and hybrid tree cutting algorithms to identify gene modules.
Module eigengenes, which summarise module expression in a single vector, were computed and used to identify and merge highly correlated modules.
3. Finally, we computed gene-module correlations (kMEs), a measure of gene-module membership, filtering out any genes which were not significantly associated with their allocated module after correcting for multiple testing using the Benjamini-Hochberg method.
Genetic prioritization of cell type co-expression networks
Genetic prioritization of WGCNA gene modules followed the same framework as for prioritizing cell types. That is, we used S-LDSC controlling for the baseline and "all genes" annotations. Gene modules annotations were constructed by assigning the module genes' kME values to variants within a 100-kb window of the genes' transcribed regions. We restricted modules to contain at least 10 genes and at most 500 genes (removing 8 out of 571 modules), because S-LDSC is not well-equipped for prioritizing annotations that span very small proportion of the genome, and unspecific modules with a large number of weakly connected genes have limited biological relevance.
Co-expression networks visualizations
To create the network visualization of the cell type rWGCNA gene modules (Supplementary Fig. 4b) ,
we computed the Pearson's correlation between module kME values (a measure of gene-module membership) and generate a weighted graph between modules using the positive correlation coefficients only. To create the network visualization of the M1 gene module (Supplementary Fig. 4c ), we computed the Pearson's correlation between genes within the module, using expression data from the cell type in which the module was identified (MEINH2). We then generate a weighted graph between genes using the positive correlation coefficients only. We then mapped MAGMA BMI gene-level Z-statistics (calculated using 100-kb windows, as described above) onto the network as node sizes. All networks were visualized using the R package 'ggraph' with weighted Fruchterman-Reingold force-directed layout.
Cell type enrichment of co-expressed gene networks
To assess if gene modules were enriched in the expression specific genes of specific cell types, we tested if module gene members exhibited higher expression specificity (ESμ) in the given cell type than nonmembers of the module (all other genes in the dataset). We obtained one-sided enrichment P-values using the Mann-Whitney U test. We controlled the FDR by using the Bonferroni method calculated over gene modules tested. and subsequently all cell types were pooled and significance was determine based on Bonferroni correction (P<0.05/347). Four cell types were significantly enriched, namely POA-NEURO66 (top marker Reln in ref. 33 ) and POA-NEURO21 (top markers Cck and Ebf3 in ref. 33 ) from the preoptic area of the hypothalamus, ARCME-NEURO29 (top markers Sf1 and Adcyap1 in ref. 17 ) from the arcuate nucleus and median eminence complex, and LHA-NEURO20 (top marker genes Ebf3 and Otb in ref. 32 ) from the lateral hypothalamus. POA, preoptic area of the hypothalamus; LHA, lateral hypothalamus; ARCME, arcuate nucleus and median eminence complex; S-LDSC, stratified-linkage disequilibrium score regression. 
